Genome-wide off-targets of drugs: risks and opportunities
Cell Biol Toxicol
.
2019 Dec;35(6):485-487.
doi: 10.1007/s10565-019-09491-7.
Epub 2019 Aug 20.
Authors
Anil K Giri
1
,
Aleksandr Ianevski
1
2
,
Tero Aittokallio
3
4
5
Affiliations
1
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00290, Helsinki, Finland.
2
Helsinki Institute for Information Technology (HIIT), Aalto University, FI-02150, Espoo, Finland.
3
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, FI-00290, Helsinki, Finland.
[email protected]
.
4
Helsinki Institute for Information Technology (HIIT), Aalto University, FI-02150, Espoo, Finland.
[email protected]
.
5
Department of Mathematics and Statistics, University of Turku, FI-20014, Turku, Finland.
[email protected]
.
PMID:
31432301
DOI:
10.1007/s10565-019-09491-7
No abstract available
Publication types
Editorial
MeSH terms
Drug Evaluation, Preclinical / trends*
Humans
Immunity, Heterologous / genetics*
Immunity, Heterologous / immunology
Off-Label Use
Small Molecule Libraries / pharmacology
Substances
Small Molecule Libraries